US Patent Issued to The Trustees of Columbia University in The City of New York, Universita Degli Studi Di Milano-Bicocca on June 23 for "Delta-2-tubulin as a biomarker and therapeutic target for peripheral neuropathy" (American, Italian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,663,425, issued on June 23, was assigned to The Trustees of Columbia University in The City of New York (New York) and Universita Degli Studi Di Milano-Bicocca (Milan).

"Delta-2-tubulin as a biomarker and therapeutic target for peripheral neuropathy" was invented by Francesca Bartolini (New York), Maria Elena Pero (New York) and Guido Cavaletti (Monza, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to delta-2-tubulin and its use as a biomarker for determining if a subject is at risk of developing peripheral neuropathy or if a subject has developed peripheral neuropathy. The present disclosure further relates to metho...